Allergen (AGN) Should Buy Pfizer (PFE), Not the Other Way Around - Analyst
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Deutsche Bank Says Pfizer (PFE) and Allergan (AGN) Deal Would Enhance Cash Access
October 29, 2015 2:28 PM EDTDeutsche Bank maintained a Buy rating on Pfizer (NYSE: PFE) with a price target of $43. Comments follow rumors related to merger talks with Allergan (NYSE: AGN). In the view of analyst Gregg Gilbert, a potential deal, dubbed 'PfizerGan', would be accretive to DCF and dilutive to EPS. Perhaps more importantly, a deal would allow enhanced access to ongoing cash flows.
Gilbert explained, "We cannot guarantee any transaction will occur and we note that it could face significant media and political... More
Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC Capital
October 29, 2015 10:40 AM EDTThe potential Allergan (NYSE: AGN)/Pfizer (NYSE: PFE) deal would bring attractive strategic and financial aspects and focus will shift to the likelihood of actually getting done if the price is right and management structure can be agreed... More
Pfizer (PFE) Confirms Discussions with Allergan (AGN)
October 29, 2015 10:10 AM EDTPfizer (NYSE: PFE) notes the announcement by Allergan (NYSE: AGN) that was released earlier today regarding a potential transaction between the companies. Pfizer confirms that it is in preliminary friendly discussions with Allergan in relation to a potential... More
